AstraZeneca gets clearance by US regulators to resume coronavirus vaccine trial

Biopharmaceutical giant AstraZeneca, developing a coronavirus vaccine with the University of Oxford, has got clearance by U.S. regulators to restart a halted trial after concerns about a volunteer falling ill. According to AstraZeneca and Oxford, the FDA reviewed data from global studies and decided it was safe to begin testing again. 

from IndiaTV World: Google News Feed https://ift.tt/31ELzrN